ONCAlert | 2017 San Antonio Breast Cancer Symposium
View all Hematology

Hematology: Articles

A Look Back at FDA News in the Month of December
A Look Back at FDA News in the Month of December
Ivosidenib Submitted for FDA Approval in IDH1+ AML
Ivosidenib Submitted for FDA Approval in IDH1+ AML
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.